Rheos Medicines logo

Rheos Medicines

A new setpoint for immunometabolism Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease. Rheos was founded by Third Rock Ventures and is located in Cambridge, MA.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://rheosrx.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
38 Sidney St, MA 02139
Cambridge
United States
Email
Contact Number
+1 857-777-4242

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/rheos-medicines-inc” connections=”true” suffix=””]

Rheos through integration of Çomics data sets _ including DNA sequencing, transcriptional, metabolomic profiling and incorporating primary patient samples, build insights that are specific to human disease.

In Mar 2018, Third Rock Ventures Launches Rheos Medicines with $60 Mn in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases.